Medicaments with cytostatic activity and use of cyclic compounds, in which the heterocyclic n-ring atoms are substituted by several glycidyl groups, in pharmaceutical compositions
Abstract
Geschildert werden Arzneimittelzubereitungen mit cytostatischer Wirksamkeit, die gekennzeichnet sind durch einen Gehalt an N-Heterocyclen, die wenigstens zwei Glycidyl-substituierte N-Atome in Amid- und/oder Imidform in das Ringsystem eingebunden enthalten. Der Glycidylrest entspricht dabei der Formel wobei R Wasserstoff oder ein Alkylrest mit 1 bis 4 C-Atomen ist. Bevorzugt bedeutet R Wasserstoff. Triglycidylisocyanurat und Diglycidylisocyanurat, die am dritten Ringstickstoff ) gegebenenfalls substituierte Kohlenwasserstoffreste aufweisen, und deren Verwendung in entsprechenden Arzneimittel- ) zubereitungen Gegenstand älterer Anmeldungen ist, werden hier nicht beansprucht.

Term
Term ended
Projected expiry passed 26 January 2001, 25.7 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0014981A2 | Cites | European Patent Office (EPO) | PD | Search report |
| FR7153M | Cites | France | X | Search report |
19 members in 8 offices
Priority claims40
| Document | Office | Kind | Date |
|---|---|---|---|
| 3003356 | Germany | A | |
| 3003356 | Germany | A | |
| 3003356 | Germany | – | |
| 3003357 | Germany | A | |
| 3003357 | Germany | A | |
| 3003357 | Germany | – | |
| 3003404 | Germany | A | |
| 3003404 | Germany | A | |
| 3003404 | Germany | – | |
| 133080 | Austria | A | |
| 133080 | Austria | A | |
| 133080 | Austria | – | |
| 133180 | Austria | A | |
| 133180 | Austria | A | |
| 133180 | Austria | – | |
| 136580 | Austria | A | |
| 136580 | Austria | A | |
| 136580 | Austria | – | |
| 164980 | Austria | A | |
| 164980 | Austria | A | |
| 164980 | Austria | – | |
| 564480 | Austria | A | |
| 564480 | Austria | A | |
| 564480 | Austria | – | |
| 133080 | – | – | – |
| 133180 | – | – | – |
| 136580 | – | – | – |
| 164980 | – | – | – |
| 3003356 | – | – | – |
| 3003357 | – | – | – |
| 3003404 | – | – | – |
| 564480 | – | – | – |
| AT19800001330 | – | – | – |
| AT19800001331 | – | – | – |
| AT19800001365 | – | – | – |
| AT19800001649 | – | – | – |
| AT19800005644 | – | – | – |
| DE19803003356 | – | – | – |
| DE19803003357 | – | – | – |
| DE19803003404 | – | – | – |
Members19
| Document | Office | Kind | |
|---|---|---|---|
| IL62021A0 | Israel | A0 | |
| IL62021D0 | Israel | D0 | |
| AU6676181A | Australia | A | |
| DE3003356A1 | Germany | A1 | |
| DE3003357A1 | Germany | A1 | |
| DE3003404A1 | Germany | A1 | |
| EP0033503A2 | European Patent Office (EPO) | A2 | |
| JPS56122313A | Japan | A | |
| EP0033503A3This record | European Patent Office (EPO) | A3 | |
| ZA81615B | South Africa | B | |
| AT370729B | Austria | B | |
| ATA564480A | Austria | A | |
| CA1172962A | Canada | A | |
| AU543383B2 | Australia | B2 | |
| CA1193547A | Canada | A | |
| EP0033503B1 | European Patent Office (EPO) | B1 | |
| AT22080T | Austria | T | |
| ATE22080T1 | Austria | T1 | |
| DE3175281D1 | Germany | D1 |
33 legal events, as 3 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4 | NLV4 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Fr: translation filedET | ET | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Designated contracting states (corrected)RBV | RBV | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for examination filed17P | 17P | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0033503
- Publication, DOCDB
- 0033503
- Publication, EPODOC
- EP0033503
- Application
- 81100544
- Application, DOCDB
- 81100544
- Application, EPODOC
- EP19810100544
Titles3
- English
- Medicaments with cytostatic activity and use of cyclic compounds, in which the heterocyclic N-ring atoms are substituted by several glycidyl groups, in pharmaceutical compositions
- French
- Médicaments à activité cytostatique et utilisation de composés cycliques, dont les N-hétérocycliques sont substitués par plusieurs groupes gycidyle, dans des formulations pharmaceutiques
- German
- Arzneimittel mit cytostatischer Wirkung sowie Verwendung von mehrfach mit Glycidylgruppen substituierten N-heterocyclischen Ringverbindungen in pharmazeutischen Zubereitungen
Classification
- CPC, 2
- C07D487/04
- C07D405/06
- IPC, 7
- A61K31 335
- A61K31 505
- A61K31 515
- C07D403 06
- A61K31 415
- C07D405 06
- C07D487 04
Designated states11
- Contracting states, 11
- Austria
- Belgium
- Switzerland
- Germany
- France
- United Kingdom
- Italy
- Liechtenstein
- Luxembourg
- Netherlands (Kingdom of the)
- Sweden